• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder

Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder

November 22, 2019
Brian Frankel, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review of: Norman SB et al, Efficacy 2019;76(8):791–799

Patients with co-occurring posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) have worse outcomes compared to patients with either diagnosis alone. Integrated approaches, in which both diagnoses are simultaneously addressed, are viewed as best practice. Providers, however, are often hesitant to offer prolonged exposure, an evidence-based therapy for PTSD, to dually diagnosed patients for fear that directly addressing patients’ trauma might worsen their drinking. This study is the first randomized trial to compare 2 therapies targeting both disorders: integrated prolonged exposure (I-PE) vs integrated coping skills without exposure (I-CS).

In the study, 119 veterans were randomly assigned to 12–16 sessions of either I-PE or I-CS. Subjects were primarily male (n = 107), and the majority had experienced several trauma events—both related and not related to combat. Primary outcomes were assessed for both PTSD symptom severity and percentage heavy drinking days (PHDD), which were measured via the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) and Timeline Followback questionnaires, respectively. Data were collected prior to treatment, post-treatment, and at 3 and 6 months following treatment.

Congruent with prior studies, PTSD severity decreased in both arms over time, and there was a significantly greater reduction in the I-PE group (p = 0.002). Regarding drinking outcomes, however, both arms were almost identical (p = 0.91). Encouragingly, regardless of whether the therapy involved exposure, PHDD dropped from approximately 50% to 20% by the end of the study, and there was a corresponding increase in days abstinent as well.

CATR’s Take
Prolonged exposure is one of the best treatments we have for PTSD, and this study helps show that it should not be withheld from patients with co-occurring AUD, especially when delivered in an integrated format that can also address alcohol use.
Addiction Treatment
KEYWORDS addiction addiction-treatment alcohol alcohol-use alcohol-use-disorder alcoholism co-occurring-disorders dual-diagnosis prolonged-exposure psychotherapy ptsd research research-update substance-use substance-use-disorders
Brian Frankel, MD

The COMBINE Study: A Core Paper in the Treatment of AUD

More from this author
www.thecarlatreport.com
Issue Date: November 22, 2019
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Medical Issues in Addiction Practice, CATR, November/December 2019
Primer: Physical Examination in Addiction Practice
Screening and Prophylaxis of Infectious Diseases in Addiction Practice
PrEP: Introduction to the Basics
Perioperative Management of Patients on Buprenorphine Maintenance
Exposure Therapy Efficacious for PTSD Co-Occurring With Alcohol Use Disorder
Varenicline and Bupropion: Soaring Again With EAGLES?
The COMBINE Study: A Core Paper in the Treatment of AUD
Featured Book
  • AUDFB1e_CoilBound_Graphic2_transparent_sm.png

    Treating Alcohol Use Disorder: A Fact Book (2023)

    All the tools and information needed to assess and treat your patients who are struggling with...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • Substance_Use_Sites.jpeg
    Addiction Treatment

    Supervised Drug Consumption Sites

    Once controversial, research clearly shows the benefit of these sites, and they have started opening in the United States.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.